BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 5822679)

  • 1. Plasma lipid and lipoprotein alterations during oral contraceptive administration.
    Sachs BA; Wolfman L; Herzig N
    Obstet Gynecol; 1969 Oct; 34(4):530-5. PubMed ID: 5822679
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipid and lipoprotein levels in a Danish population.
    Dyerberg J; Hjorne N
    Acta Med Scand; 1972 May; 191(5):413-21. PubMed ID: 4337998
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study with 1 mg of ethynodiol diacetate and 0.1 mg (1.0-0.1) mestranol].
    Mateos Candano M; Bolio Arista R
    Ginecol Obstet Mex; 1967; 22(127):151-61. PubMed ID: 5604500
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of some ovulation inhibitors on the different plasma lipid fractions.
    Brody S; Kerstell J; Nilsson L; Svanborg A
    Acta Med Scand; 1968; 183(1-2):1-7. PubMed ID: 5669819
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of hypertriglyceridaemia associated with contraceptive steroids.
    Kissebah AH; Harrigan P; Wynn V
    Horm Metab Res; 1973 May; 5(3):184-90. PubMed ID: 4351691
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of ethynodiol diacetate and mestranol on blood glucose and plasma insulin. I. Six month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Int J Fertil; 1971; 16(2):55-65. PubMed ID: 5092534
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of oral contraceptives on serum lipids.
    Schenker JG; Pinson A; Polishuk WZ
    Fertil Steril; 1971 Sep; 22(9):604-8. PubMed ID: 5571067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet adhesiveness and lipoprotein lipase activity in controls and in subjects taking oral contraceptives.
    Ham JM; Rose R
    Am J Obstet Gynecol; 1969 Oct; 105(4):628-31. PubMed ID: 4898817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogens, gestagens and lipid metabolism].
    Lauritzen C
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:22-31. PubMed ID: 4505204
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma insulin responses to glucose in normal and subclinical diabetic women treated with oral contraceptive agents.
    Beck P; Wells SA
    Diabetes; 1968; 17():307-8. PubMed ID: 5689961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term effect of hormonal contraceptives on the behavior of serum lipids].
    Klinger G; Carol W; Hoppe H; Müller B; Bonow A
    Zentralbl Gynakol; 1977; 99(5):271-6. PubMed ID: 194435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptives on glycerides and sterol esters of human cervical mucus.
    Singh EJ; Swartwout JR
    Am J Obstet Gynecol; 1972 Oct; 114(4):484-91. PubMed ID: 4120115
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipids during oral contraceptive exposure.
    Corredor DG; Mendelsohn LV; Sabeh G; Sunder JH; Danowski TS
    Clin Pharmacol Ther; 1970; 11(2):188-93. PubMed ID: 5416850
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophoretic study of serum proteins in women using oral contraceptive for 1 to 3 years.
    Gupta P; Sharma PK; Saxena SB; Garg S; Nath S
    J Obstet Gynaecol India; 1973 Apr; 23(2):148-51. PubMed ID: 4806731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen contents and progestagenic activity of 2 compounds containing ethynodiol diacetate].
    Jedrzejewski M; Krzywdziński K; Teter J
    Endokrynol Pol; 1972; 23(6):538-7. PubMed ID: 4680323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Temporary control of fertility with ethynodiol diacetate and mestranol (1.0/0.1) in women with a high obstetrical risk. Study of 2400 cycles].
    Alvarado Duran A; Lopez Llera M; Carbia Aguilar E
    Ginecol Obstet Mex; 1968 Feb; 23(136):291-300. PubMed ID: 5681098
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of a contraceptive (ovulene) on mouse mammary carcinogenesis].
    Coezy E; Rudali G
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):205-9. PubMed ID: 5462688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.